Detection of tumor specific changes in nucleic acids in body fluids of patients with malignancies

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00009521

Enrollment

1000

Registered

2016-04-05

Start date

2014-10-22

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

all types of tumor

Interventions

Group 1: Detection of tumor specific changes in nucleic acids in body fluids

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: none

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Proportion of patients with malignant disease and a known tumor-specific , genetic Change detection with the corresponding genetic modification in a Body fluid such as blood, plasma, saliva or urine	—

Secondary

Measure	Time frame
- Correlation of detection of tumor-specific , genetic alterations in Body fluids with the clinical course ( imaging : recurrence , response ) and clinical endpoints - Correlation of detection of tumor-specific , genetic alterations in Body fluids with clinical endpoints (progressionfree- and overall survival )	—

Countries

Germany

Contacts

Public ContactNikolas von Bubnoff

Universitätsklinikum Freiburg

nikolas.bubnoff@uniklinik-freiburg.de+49 761 270 37850

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026